Issue: January 2018
January 22, 2018
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Heraeus Medical announces Palacos bone cement portfolio is directly available in the US
Issue: January 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Heraeus Medical Inc. announced that since Jan. 3, 2018, it has been selling the Palacos portfolio of bone cement products direct through Heraeus Medical LLC in the United States, according to a company press release.
“The company is extremely excited about the opportunity to support total joint surgeons directly in the U.S. in providing consistent, predictable outcomes with the potential for lower revision rates,” Andrew Williamson, PhD, Heraeus Medical board member, said in the release.
Reference: